BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 427795)

  • 1. Tumor regression after intralesional injection of mycobacterial components emulsified in 2,6,10,15,19,23-hexamethyl-2,6,10,14,18,22-tetracosahexaene (squalene), 2,6,10,15,19,23-hexamethyltetracosane (squalane), peanut oil, or mineral oil.
    Yarkoni E; Rapp HJ
    Cancer Res; 1979 May; 39(5):1518-20. PubMed ID: 427795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of oil concentration on the efficacy of tumor regression by emulsified components of mycobacteria.
    Yarkoni E; Rapp HJ
    Cancer Res; 1979 Feb; 39(2 Pt 1):535-7. PubMed ID: 761228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of surfactant concentration on the antitumor activity of emulsified components of mycobacteria.
    Yarkoni E; Rapp HJ
    Cancer Res; 1980 Apr; 40(4):975-8. PubMed ID: 7357563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of type of oil and surfactant concentration on the efficacy of emulsified Mycobacterium bovis BCG cell walls to induce tumor regression in guinea pigs.
    Yarkoni E; Rapp HJ
    Infect Immun; 1980 Jun; 28(3):881-6. PubMed ID: 6995325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor regression after intralesional injection of emulsified trehalose-6,6'-dimycolate (cord factor): efficacy increases with oil concentration.
    Yarkoni E; Meltzer MS; Rapp HJ
    Int J Cancer; 1977 Jun; 19(6):818-21. PubMed ID: 326683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local tumor regression after intralesional injection of croton oil.
    Yarkoni E; Rapp HJ
    J Natl Cancer Inst; 1979 Aug; 63(2):503-5. PubMed ID: 287839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy with an intralesionally administered synthetic cord factor analogue.
    Yarkoni E; Rapp HJ; Polonsky J; Lederer E
    Int J Cancer; 1978 Nov; 22(5):564-9. PubMed ID: 721317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antitumor effect of a synthetic cord factor, 6,6'-di-O-decanoyl-alpha, alpha-trehalose (SS 554) in mice].
    Kohya H; Ishii F; Takano S; Katori T; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1986 May; 13(5):1897-904. PubMed ID: 3754712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity of emulsified trehalose-6,6'-dimycolate (cord factor) in mice depends on size distribution of mineral oil droplets.
    Yarkoni E; Rapp HJ
    Infect Immun; 1978 Jun; 20(3):856-60. PubMed ID: 669824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of experimental cancer with a mixture of synthetic muramyl dipeptide and trehalose dimycolate.
    Yarkoni E; Lederer E; Rapp HJ
    Infect Immun; 1981 Apr; 32(1):273-6. PubMed ID: 7216489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases.
    Yarkoni E; Ashley MP; Zbar B; Sugimoto T; Rapp HJ
    Cancer Res; 1982 Jul; 42(7):2544-6. PubMed ID: 7083146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of a murine fibrosarcoma after intralesional injection of a synthetic C39 glycolipid related to cord factor.
    Yarkoni E; Rapp HJ; Polonsky J; Varenne J; Lederer E
    Infect Immun; 1979 Nov; 26(2):462-6. PubMed ID: 546783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of experimental Newcastle disease water-in-oil oil-emulsion vaccines formulated from squalane and squalene.
    Stone HD; Xie ZX
    Avian Dis; 1990; 34(4):979-83. PubMed ID: 2149264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of oil and Tween concentrations on enhanced endotoxin lethality in mice pretreated with emulsified trehalose-6,6'-dimycolate (cord factor).
    Yarkoni E; Rapp HJ
    Infect Immun; 1979 May; 24(2):571-2. PubMed ID: 378860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of intravenous mycobacterial cell wall skeleton and trehalose dimycolate attached to oil droplets.
    Vosika G; Giddings C; Gray GR
    J Biol Response Mod; 1984 Dec; 3(6):620-6. PubMed ID: 6512562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumor chemoimmunotherapy with mitomycin C and components from mycobacteria in regression of line 10 tumors in guinea pigs.
    McLaughlin CA; Cantrell JL; Ribi E; Goldberg EP
    Cancer Res; 1978 May; 38(5):1311-6. PubMed ID: 205361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor effect of a synthetic cord factor, 6,6'-di-O-decanoyl-alpha,alpha-trehalose (SS554), in mice.
    Kohya H; Ishii F; Takano S; Katori T; Ebina T; Ishida N
    Jpn J Cancer Res; 1986 Jun; 77(6):602-9. PubMed ID: 3089995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomedical applications of chromatographic fraction containing trehalose dimycolate in squalane emulsion.
    Masihi KN; Lange W; Ozel M
    J Chromatogr; 1988 May; 440():473-8. PubMed ID: 3042798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor regression and enhancement resulting from immunotherapy with Bacillus Calmette-GuĂ©rin and neuraminidase.
    Sparks FC; Breeding JH
    Cancer Res; 1974 Dec; 34(12):3262-9. PubMed ID: 4471640
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effect of BCG cell-wall skeletons (BCG-CWS) emulsified in squalane on tumor growth and metastasis in mice.
    Yoo YC; Hata K; Lee KB; Azuma I
    Arch Pharm Res; 2002 Aug; 25(4):522-7. PubMed ID: 12214866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.